期刊文献+

速尿对整体大鼠肾11β-羟基类固醇脱氢酶活性的影响 被引量:2

The effects of furosemide on renal 11β-hydroxysteroid dehydrogenase and serum electrolytes in intact rats
下载PDF
导出
摘要 目的 研究速尿对整体大鼠肾 11β -羟基类固醇脱氢酶活性的影响 ,探讨速尿引起低血钾可能的新生化机制。方法 大鼠给予速尿单次和多次 (bid× 2 0d)灌胃 ,HPLC法测定大鼠尿中脱氢皮质酮 (A)与皮质酮 (B)的比值。全自动生化分析仪测定给药后血K+ 、Na+ 、Cl-浓度。结果 速尿 (40、10 0、2 5 0mg·kg-1)单次和 (10、2 0、10 0mg·kg-1)多次给药后 ,尿中A/B比值分别下降了 2 9.0 %、5 8.6 %、6 0 .9%和 14 .4 %、36 .0 %、4 4 .9%。速尿 (2 0、10 0mg·kg-1)连续给药 2 0d ,血钾较对照组显著降低 (P <0 .0 1) ,血钾降低与A/B的降低呈正相关 (P <0 .0 1)。结论 速尿在体给药可抑制肾 11β-HSD活性。 Objective To investigate the effects of furosemide (Fur) on 11β-hydroxysteroid dehydrogenase (11β-HSD) activity and serum electrolytes in intact rats, and the correlation between the decrease of 11β-HSD activity and the hypokalemia induced by Fur. Methods SD rats were given Fur of single dose (40, 100, and 250 mg·kg -1 ) or of successive doses (10, 20, and 100 mg·kg -1 , bid×20 d) by gavage. The activity of 11β-HSD was evaluated by measuring the ratio of dehydrocorticosterone (A) to corticosterone (B) in urine by HPLC method. Results After giving single-dose Fur and multiple-dose Fur, the urinary ratio of A/B was reduced by 29.0 %, 58.6 %, 60.9 % and 14.4 %, 36.0 %, 44.9 % respectively. The serum potassium was significantly reduced by multiple-dose Fur (20 and 100 mg·kg -1 ) (P<0.01). The reduction of serum potassium was positively correlated with the lowering of A/B ratio (P<0.01). Conclusion The inhibition of renal 11β-HSD activity may be a new biochemical mechanism for hypokalemia induced by Fur.
出处 《徐州医学院学报》 CAS 2002年第1期3-6,共4页 Acta Academiae Medicinae Xuzhou
基金 国家自然科学基金资助项目 (No :396 70 84 4 )
关键词 11Β-羟基类固醇脱氢酶 高血压 低血钾 速尿 11β-hydroxysteroid dehydrogenase hypertension hypokalemia furosemide
  • 相关文献

同被引文献10

  • 1陈雯,谢晓华,常连庆,孙愚,张颖,牟丽华,刘宁,刘秀华.醛固酮上调大鼠组织钙调神经磷酸酶活性及抑制血浆一氧化氮水平[J].高血压杂志,2005,13(11):721-724. 被引量:4
  • 2Krozowski Z,MaGuire JA,Stein-Oakley AN,et al.Immunohistochemical location of the 11β-hydroxysteroid dehydrogenase type Ⅱ enzemy in human kidney and placenta[J].J Clin Endocrinol Metab,1998,80(12):2203-2209.
  • 3Ruschitzka F,Quaschning T,Noll G,et al.Endothlin 1 type A receptor antagonism prevents vascular dysfunction and hypertensin induced by 11β-hydroxysteroid dehydrogenase inhibition:role of nitric oxide[J].Circulation,2001,103(25):3129-3135.
  • 4Ignarro LJ,Napoli C,Loscalzo J.Nitric oxide donors and cardio-vascular agents modulating the bioactivity of nitric oxide[J].Circ Res,2002,90(1):21-28.
  • 5Nagata D,Takahashi M,Sawai K,et al.Molecular mechanism of the inhibitory effect of aldosterone on endothelial NO synthase activity[J].Hypertension,2006,48(1):165 -171.
  • 6Krozowski Z, MaGuire JA, Stein-Oakley AN, et al. Immunohistochemical location of the 11β-hydroxysteroid dehydrogenase type Ⅱ enzemy in human kidney and placenta[J]. J Clin Endocrinol Metab, 1998,80(12):2203-2209.
  • 7Brem AS, Bina BR, King TC, et al. Localization of 11β-OH steroid dehydrogenase isoforms in aortic endothelial cells[J]. Hypertension,1998, 31:456-462.
  • 8Oberleithnar H, Ludwig T, Riethmüller C, et al. Human endothelium,target for aldosterone[J]. Hypertension,2004,43:952.
  • 9Nagata D, Takahashi M, Sawai K, et al. Molecular mechanism of the inhibitory effect of aldosterone on endothelial NO synthase activity[J]. Hypertension, 2006, 48: 165-171.
  • 10龚素珍,刘培庆,鲁伟,王庭槐,符史干,谈智,潘敬运.醛固酮对心室成纤维细胞分泌内皮素的影响[J].生理学报,2001,53(1):23-26. 被引量:8

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部